Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function

被引:223
作者
Tsai, YC
Fishman, PS
Thakor, NV
Oyler, GA
机构
[1] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA
[3] Baltimore Vet Affairs Med Ctr, Res Serv, Baltimore, MD 21201 USA
关键词
D O I
10.1074/jbc.M212235200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkin, the most commonly mutated gene in familial Parkinson's disease, encodes an E3 ubiquitin ligase. A number of candidate substrates have been identified for parkin ubiquitin ligase action including CDCrel-1, o-glycosylated alpha-synuclein, Pael-R, and synphilin-1. We now show that parkin promotes the ubiquitination and degradation of an expanded polyglutamine protein. Overexpression of parkin reduces aggregation and cytotoxicity of an expanded polyglutamine ataxin-3 fragment. Using a cellular proteasome indicator system based on a destabilized form of green fluorescent protein, we demonstrate that parkin reduces proteasome impairment and caspase-12 activation induced by an expanded polyglutamine protein. Parkin forms a complex with the expanded polyglutamine protein, heat shock protein 70 (Hsp70) and the proteasome, which may be important for the elimination of the expanded polyglutamine protein. Hsp70 enhances parkin binding and ubiquitination of expanded polyglutamine protein in vitro suggesting that Hsp70 may help to recruit misfolded proteins as substrates for parkin E3 ubiquitin ligase activity. We speculate that parkin may function to relieve endoplasmic reticulum stress by preserving proteasome activity in the presence of misfolded proteins. Loss of parkin function and the resulting proteasomal impairment may contribute to the accumulation of toxic aberrant proteins in neurodegenerative diseases including Parkinson's disease.
引用
收藏
页码:22044 / 22055
页数:12
相关论文
共 84 条
[1]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[2]   Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy [J].
Bailey, CK ;
Andriola, IFM ;
Kampinga, HH ;
Merry, DE .
HUMAN MOLECULAR GENETICS, 2002, 11 (05) :515-523
[3]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[4]  
Bercovich B, 1997, J BIOL CHEM, V272, P9002
[5]   Evidence for proteasome involvement in polyglutamine disease:: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro [J].
Chai, YH ;
Koppenhafer, SL ;
Shoesmith, SJ ;
Perez, MK ;
Paulson, HL .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :673-682
[6]   Mechanisms of chaperone suppression of polyglutamine disease:: selectivity, synergy and medullation of protein solubility in Drosophila [J].
Chan, HYE ;
Warrick, JM ;
Gray-Board, GL ;
Paulson, HL ;
Bonini, NM .
HUMAN MOLECULAR GENETICS, 2000, 9 (19) :2811-2820
[7]   Dissociation from BiP and retrotranslocation of unassembled immunoglobulin light chains are tightly coupled to proteasome activity [J].
Chillarón, J ;
Haas, IG .
MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (01) :217-226
[8]   Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1:: implications for Lewy-body formation in Parkinson disease [J].
Chung, KKK ;
Zhang, Y ;
Lim, KL ;
Tanaka, Y ;
Huang, H ;
Gao, J ;
Ross, CA ;
Dawson, VL ;
Dawson, TM .
NATURE MEDICINE, 2001, 7 (10) :1144-1150
[9]   The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins [J].
Connell, P ;
Ballinger, CA ;
Jiang, JH ;
Wu, YX ;
Thompson, LJ ;
Höhfeld, J ;
Patterson, C .
NATURE CELL BIOLOGY, 2001, 3 (01) :93-96
[10]   Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice [J].
Cummings, CJ ;
Reinstein, E ;
Sun, YL ;
Antalffy, B ;
Jiang, YH ;
Ciechanover, A ;
Orr, HT ;
Beaudet, AL ;
Zoghbi, HY .
NEURON, 1999, 24 (04) :879-892